Peter Sandner

5.4k total citations
143 papers, 3.7k citations indexed

About

Peter Sandner is a scholar working on Molecular Biology, Physiology and Psychiatry and Mental health. According to data from OpenAlex, Peter Sandner has authored 143 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 40 papers in Physiology and 35 papers in Psychiatry and Mental health. Recurrent topics in Peter Sandner's work include Nitric Oxide and Endothelin Effects (34 papers), Sexual function and dysfunction studies (33 papers) and Urinary Bladder and Prostate Research (28 papers). Peter Sandner is often cited by papers focused on Nitric Oxide and Endothelin Effects (34 papers), Sexual function and dysfunction studies (33 papers) and Urinary Bladder and Prostate Research (28 papers). Peter Sandner collaborates with scholars based in Germany, United States and Switzerland. Peter Sandner's co-authors include Armin Kurtz, Mario Maggi, Johannes Peter Stasch, Hanna Tinel, Linda Vignozzi, Annamaria Morelli, Gabriella Barbara Vannelli, Benedetta Fibbi, Sandra Filippi and Joachim Hütter and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Peter Sandner

138 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Sandner Germany	35	1.2k	890	802	794	684	143	3.7k
Yang Xia United States	45	1.6k 1.4×	389 0.4×	66 0.1×	437 0.6×	761 1.1×	145	5.8k
Nobuo Moriyama Japan	31	1.2k 1.0×	432 0.5×	530 0.7×	145 0.2×	248 0.4×	119	2.7k
Luca Rampoldi Italy	32	1.5k 1.3×	260 0.3×	89 0.1×	562 0.7×	459 0.7×	63	4.0k
G Benoît France	45	2.3k 2.0×	507 0.6×	704 0.9×	796 1.0×	335 0.5×	281	6.9k
Thomas M. Cocks Australia	37	1.4k 1.2×	308 0.3×	248 0.3×	137 0.2×	2.6k 3.8×	79	5.3k
M. Serio Italy	32	918 0.8×	1.0k 1.2×	142 0.2×	79 0.1×	365 0.5×	153	3.0k
Nicholas J. Laping United States	34	3.7k 3.2×	295 0.3×	263 0.3×	61 0.1×	597 0.9×	82	6.3k
Richard J. Paul United States	40	3.1k 2.7×	302 0.3×	95 0.1×	104 0.1×	1.2k 1.8×	110	5.0k
Kirsten Madsen Denmark	38	2.9k 2.5×	490 0.6×	61 0.1×	101 0.1×	745 1.1×	128	4.4k
Jianhua Feng China	29	4.5k 3.9×	240 0.3×	59 0.1×	279 0.4×	939 1.4×	101	6.8k

Countries citing papers authored by Peter Sandner

Since Specialization

Citations

This map shows the geographic impact of Peter Sandner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sandner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sandner more than expected).

Fields of papers citing papers by Peter Sandner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sandner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sandner. The network helps show where Peter Sandner may publish in the future.

Co-authorship network of co-authors of Peter Sandner

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sandner. A scholar is included among the top collaborators of Peter Sandner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sandner. Peter Sandner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sandner, Peter, et al.. (2025). Discovery of the first isoform-specific sGC activator: Selective activation of GC-1 by runcaciguat. European Journal of Pharmacology. 996. 177557–177557.

Mathar, Ilka, et al.. (2025). Runcaciguat activates soluble guanylyl cyclase via the histidine essential for heme binding and nitric oxide activation. Biochemical Pharmacology. 232. 116739–116739. 1 indexed citations

Benza, Raymond L., Ekkehard Grünig, Peter Sandner, Johannes‐Peter Stasch, & Gérald Simonneau. (2024). The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase. European Respiratory Review. 33(171). 230183–230183. 18 indexed citations

Kala, Petr, et al.. (2024). Soluble guanylyl cyclase stimulators and activators: Promising drugs for the treatment of hypertension?. European Journal of Pharmacology. 987. 177175–177175. 2 indexed citations

Fei, Lingyan, Ilka Mathar, Lisa Dietz, et al.. (2024). Activating soluble guanylyl cyclase attenuates ischemic kidney damage. Kidney International. 107(3). 476–491. 9 indexed citations

Sharma, Arpeeta, Muthukumar Mohan, Phillip Kantharidis, et al.. (2023). Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase. Frontiers in Cardiovascular Medicine. 10. 1220095–1220095. 6 indexed citations

Schepers, Melissa, Sébastien Foulquier, Annelies Bronckaers, et al.. (2023). Soluble guanylyl cyclase: A novel target for the treatment of vascular cognitive impairment?. Pharmacological Research. 197. 106970–106970. 11 indexed citations

Aydoğdu, Özgü, Patrik Aronsson, Thomas Carlsson, et al.. (2022). Treatment with the soluble guanylate cyclase activator BAY 60-2770 restores in vitro bladder contractile responses in a rat model of chronic prostatitis. SHILAP Revista de lepidopterología. 4. 100520–100520.

Colburn, Trenton D., Andrew G. Horn, K. Sue Hageman, et al.. (2021). Capillary hemodynamics and contracting skeletal muscle oxygen pressures in male rats with heart failure: Impact of soluble guanylyl cyclase activator. Nitric Oxide. 119. 1–8. 2 indexed citations

10.

Argyrousi, Elentina K., Nick P. van Goethem, Fuqiang Zhao, et al.. (2021). Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume. Biomedicines. 9(8). 1047–1047. 11 indexed citations

11.

Bénardeau, Agnès, Michael G. Hahn, Michael Gerisch, et al.. (2020). The Novel Soluble Guanylyl Cyclase (sGC) Activator Runcaciguat Induced Renal Vasodilation and Reduced Kidney Damage in a Rat CKD Model. Journal of the American Society of Nephrology. 31(10S). 232–232. 1 indexed citations

12.

Koziol‐White, Cynthia, et al.. (2019). Soluble Guanylate Cyclase Agonists Induce Bronchodilation in Human Small Airways. American Journal of Respiratory Cell and Molecular Biology. 62(1). 43–48. 18 indexed citations

13.

Sandner, Peter, et al.. (2019). Thermal shift assay: Strengths and weaknesses of the method to investigate the ligand-induced thermostabilization of soluble guanylyl cyclase. Journal of Pharmaceutical and Biomedical Analysis. 181. 113065–113065. 12 indexed citations

14.

Park, Min Soo, Peter Sandner, & Thomas Krieg. (2018). cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway. Basic Research in Cardiology. 113(4). 24–24. 57 indexed citations

15.

Mathar, Ilka, et al.. (2018). Abstract 15553: The sGC Stimulator Vericiguat Improved Outcome in a Rodent Model of Heart Failure With Preserved Ejection Fraction (HFpEF). Circulation. 1 indexed citations

16.

Mondritzki, Thomas, Philip Boehme, Julia Vogel, et al.. (2017). New pulmonary hypertension model in conscious dogs to investigate pulmonary-selectivity of acute pharmacological interventions. European Journal of Applied Physiology. 118(1). 195–203. 5 indexed citations

17.

Mathar, Ilka, Axel Kretschmer, Elke Hartmann, Peter Kolkhof, & Peter Sandner. (2017). Abstract 17778: Combination of Soluble Guanylate Cyclase Stimulation and Mineralocorticoid Receptor Antagonism as New Treatment Option for Heart Failure With Preserved Ejection Fraction (hfpef): Results From A Preclinical Study With Vericiguat and Finerenone. Circulation. 2 indexed citations

18.

Albersen, Maarten, Loes Linsen, Hanna Tinel, Peter Sandner, & Koenraad van Renterghem. (2013). Synergistic Effects of BAY 60-4552 and Vardenafil on Relaxation of Corpus Cavernosum Tissue of Patients with Erectile Dysfunction and Clinical Phosphodiesterase Type 5 Inhibitor Failure. The Journal of Sexual Medicine. 10(5). 1268–1277. 24 indexed citations

19.

Filippi, Sandra, Annamaria Morelli, Peter Sandner, et al.. (2007). Characterization and functional role of an androgen-dependent PDE5 activity in bladder. 14. 1 indexed citations

20.

Sandner, Peter, et al.. (1998). Frankfurt. Auschwitz. : die nationalsozialistische Verfolgung der Sinti und Roma in Frankfurt am Main. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact